Fluticasone Furoate, Umeclidinium Bromide / Vilanterol Trifenatate
Common brands: Trelegy Ellipta, Albuterol, Ventolin Hfa, Proair Digihaler, Proair Respiclick
Top reporter: Glaxosmithkline Llc
Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Interleukin-4 Receptor alpha Antagonist [EPC]Loop Diuretic [EPC]Proton Pump Inhibitor [EPC]
39,140
Total Reports
28,747
Serious Reports
3,184
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.13%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Fluticasone Furoate, Umeclidinium Bromide / Vilanterol Trifenatate.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DYSPNOEA | 5,453 | |
| 2 | DRUG INEFFECTIVE | 3,315 | |
| 3 | PRODUCT DOSE OMISSION ISSUE | 3,095 | |
| 4 | WRONG TECHNIQUE IN DEVICE USAGE PROCESS | 3,071 | |
| 5 | PRODUCT COMPLAINT | 2,739 | |
| 6 | COUGH | 2,654 | |
| 7 | DEATH | 2,294 | |
| 8 | PNEUMONIA | 1,949 | |
| 9 | ASTHMA | 1,661 | |
| 10 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 1,505 | |
| 11 | FATIGUE | 1,278 | |
| 12 | PRODUCT USE IN UNAPPROVED INDICATION | 1,234 | |
| 13 | OFF LABEL USE | 1,221 | |
| 14 | HEADACHE | 1,200 | |
| 15 | DYSPHONIA | 1,123 | |
| 16 | CONDITION AGGRAVATED | 1,048 | |
| 17 | HOSPITALISATION | 974 | |
| 18 | NAUSEA | 974 | |
| 19 | WHEEZING | 911 | |
| 20 | DIZZINESS | 888 | |
| 21 | INCORRECT DOSE ADMINISTERED | 876 | |
| 22 | DIARRHOEA | 861 | |
| 23 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 855 | |
| 24 | PRODUCTIVE COUGH | 852 | |
| 25 | MALAISE | 814 | |
| 26 | COVID-19 | 774 | |
| 27 | FALL | 765 | |
| 28 | ARTHRALGIA | 747 | |
| 29 | PAIN | 722 | |
| 30 | PRODUCT DISPENSING ERROR | 717 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.